Your browser doesn't support javascript.
loading
Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies.
Do, Le-Duy; Chanson, Eve; Desestret, Virginie; Joubert, Bastien; Ducray, François; Brugière, Sabine; Couté, Yohann; Formaglio, Maité; Rogemond, Veronique; Thomas-Antérion, Catherine; Borrega, Laura; Laurens, Brice; Tison, Francois; Curot, Jonathan; De Brouker, Thomas; Lebrun-Frenay, Christine; Delattre, Jean-Yves; Antoine, Jean-Christophe; Honnorat, Jerome.
Affiliation
  • Do LD; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Chanson E; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Desestret V; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Joubert B; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Ducray F; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Brugière S; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Couté Y; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Formaglio M; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Rogemond V; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Thomas-Antérion C; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Borrega L; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Laurens B; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Tison F; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Curot J; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • De Brouker T; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Lebrun-Frenay C; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Delattre JY; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Antoine JC; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
  • Honnorat J; From the French Reference Center on Paraneoplastic Neurological Syndrome (L.-D.D., E.C., V.D., B.J., F.D., V.R., J.-Y.D., J.-C.A., J.H.) and Service de Neurologie D (V.D., M.F.), Hôpital Neurologique, Hospices Civils de Lyon; Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310 (L.-D.D., E.C., V.D., B.J
Neurology ; 88(6): 514-524, 2017 02 07.
Article in En | MEDLINE | ID: mdl-28062719
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Autoantibodies / Brain / Adenylate Kinase / Limbic Encephalitis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Autoantibodies / Brain / Adenylate Kinase / Limbic Encephalitis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article